1 asset in Pulmonary Sarcoidosis
Therapeutic assets addressing Pulmonary Sarcoidosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Semaglutide Pulmonary Sarcoidosis | University of Pennsylvania | P1/2 | CCC (48) |